IntelGenx Technologies Corp. (CVE:IGX – Get Free Report) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.58 and traded as low as C$0.58. IntelGenx Technologies shares last traded at C$0.58, with a volume of 11,848 shares trading hands.
IntelGenx Technologies Trading Up 1.8%
The firm has a market capitalization of C$87.32 million and a price-to-earnings ratio of -7.44. The business has a 50-day moving average of C$0.58 and a two-hundred day moving average of C$0.58. The company has a quick ratio of 2.69, a current ratio of 2.77 and a debt-to-equity ratio of 164.62.
IntelGenx Technologies Company Profile
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.
Featured Articles
- Five stocks we like better than IntelGenx Technologies
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
